康臣药业集团有限公司（股票代码：01681）6月30日发布翌日披露报表。公告显示，公司当日在香港联交所场内回购普通股63,000股，约占回购前已发行股本的0.0075%，每股回购价介乎12.50港元至12.58港元，总耗资约79.16万港元。
本次回购后，公司已发行股本变动为839,049,111股，库藏股数量增至2,498,000股。此前回购授权于2026年5月26日获股东大会通过，授权总数为84,120,311股，公司迄今已回购2,154,000股，占该授权总数约2.5606%。
公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由公司秘书高海恩签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.